Skip to main content
Premium Trial:

Request an Annual Quote

Guardant Health Providing Liquid Biopsy for Japanese GI Cancer Basket Trial

NEW YORK (GenomeWeb) – Guardant Health said today that its Guardant360 liquid biopsy assay will be used in a large ongoing trial organized by the National Cancer Center Hospital East (NCCE) in Kashiwa, Japan.

The study is matching patients with advanced gastrointestinal cancer, including gastric and colorectal cancer, to novel therapies that target specific gene alterations. The liquid biopsy arm, called GOZILA (Guardant Originates in ZIpangu Liquid biopsy Arrival) will initially use Guardant360 to test 200 advanced CRC patients whose cancer has progressed after standard treatment with anti-EGFR therapy.

Those who test positive for amplification in the ERBB2 gene will be enrolled in a clinical trial exploring the effectiveness of changing to an anti-ERBB2 combination targeted therapy with trastuzumab and pertuzumab. The study will then expand to include 2,000 patients with a variety of GI cancers and treatment arms.

The study is part of a larger effort in Japan, called SCRUM-Japan GI-SCREEN, to assess the genomic profile of patients with advanced cancer in their GI tracts and match them to associated targeted therapies.

"Tumors that metastasize from the GI tract can be especially difficult to access, making tissue specimen collection challenging. Through a simple blood draw, we can help match these patients to the experimental treatments being studied by NCCE Japan," Guardant Health CEO Helmy Eltoukhy said in a statement.

The Scan

Pig Organ Transplants Considered

The Wall Street Journal reports that the US Food and Drug Administration may soon allow clinical trials that involve transplanting pig organs into humans.

'Poo-Bank' Proposal

Harvard Medical School researchers suggest people should bank stool samples when they are young to transplant when they later develop age-related diseases.

Spurred to Develop Again

New Scientist reports that researchers may have uncovered why about 60 percent of in vitro fertilization embryos stop developing.

Science Papers Examine Breast Milk Cell Populations, Cerebral Cortex Cellular Diversity, Micronesia Population History

In Science this week: unique cell populations found within breast milk, 100 transcriptionally distinct cell populations uncovered in the cerebral cortex, and more.